Pfizer, 21 days for the second dose? No problem even if the booster of the vaccine is done at 42 days. This was stated by Marco Cavaleri, head of Vaccines and Therapeutic Products for Covid-19 of the European Medicines Agency Ema, today during a meeting with the press to update on the activities of the EU body in the context of the pandemic. Read also “Data from clinical trials on the Pfizer vaccine in the adolescent age group are being evaluated” with the intention of approving an extension of use for this population as well. We aim to speed up this procedure in order to reach an opinion at the end of this month, “he later stressed.” We are also working in parallel to increase production capacity and to help manufacturers bring more supplies of anti-Covid vaccines, of which there is a huge need not only in the EU but also in other parts of the world. And in this sense we are trying to speed up procedures that could allow the approval of other production sites “, explained Cavaleri, also stating:” We constantly monitor the performance of anti-Covid vaccines in the phase post authorization and we are closely following “the issue of” rare thrombosis reported after vaccination with AstraZeneca and J&J to better understand what is the mechanism behind these adverse events “looking at who is affected. Also” we are proactively talking with the manufacturers of anti-Covid vaccines to make sure we are prepared in case there is a need for an update of the composition “of these products” should variants emerge capable of escape the immunity “induced by current vaccines. “There does not seem to be this circumstance at the moment, but we must be ready and that is why it is important to continue this work.”